viewWestminster Group PLC

Westminster sees orders surge for fever screening equipment


  • A security and managed services business
  • Based in Banbury, operates in fifty countries
  • Won a potential company-changing contract at Port of Tema
  • Demand for fever screens at unprecedented levels

Quick facts: Westminster Group PLC

Price: 9.155 GBX

Market: AIM
Market Cap: £14.69 m

What it does

Westminster Group PLC (LON:WSG) specialises in screening and security at container ports, airports, transport installations and buildings.

For example, the company has a long -term passenger baggage screening contract at an airport in West Africa.

Westminster receives a fee from all passengers flying in and out of the airport that is paid by the airlines.

Turkish Airlines is the latest airline to start to use the airport.

The Tema contract will be a similar long-term recurring revenue award with Westminster receiving payment for each unit going through the port whether it is screened or not.

How it's doing

Westminster Group racked up its fourth consecutive year of double-digit percentage revenue growth in 2019.

Reporting numbers for the year ended December 31, 2019, Westminster said its revenues rose 63% to £10.9mln in 2019, up from £6.7mln in 2018, with a 46% increase in recurring revenues to £5.6mln, up from £3.8mln the year before.

The group said its Managed Services division saw revenues jump by 50% to £5.5mln, up from £3.7mln the previous year, while the Technology Division’s top line veered 80% northwards to £5.4mln from £3.0mln.

Revenues in the first quarter of 2020 were up 22% year-on-year at £4.5mln with the company making “a healthy profit” of several hundred thousand pounds in the quarter both before and after-tax as it begins to benefit from new contracts.

What the boss says, CEO Peter Fowler

“As a business, we are operationally geared in that we have relatively fixed operating costs and as our revenues continue to grow our profitability will grow proportionally faster.  In this respect, we believe we are now approaching an inflexion point,” the group added in its statement."


Inflexion points

  • Contracts awarded for fever screening equipment
  • Port of Tema continues to ramp up
  • New managed services contracts signed 

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Westminster Group PLC named herein, including the promotion by the Company of Westminster Group PLC in any Content on the Site, the Company...



Revive Therapeutics: Analyst sees 'substantial upside potential' as key...

Proactive Research analyst Ed Stacey says Revive Therapeutics (CSE:RVV)(OTCQB:RVVTF) is a speciality life sciences company focussed on repurposing drugs for rare and infectious diseases and has a pipeline of of three main platforms. One of them is Bucillamine (BUC) which is a medication with a...

2 weeks ago

2 min read